Our purpose is to report the development and psychometric properties of a generic computer-delivered measure of health-related quality of life (HRQL) suitable for children aged 6 to 11 years, the Exeter HRQL scale (EHRQL). The theoretical model adopted is based on a definition of HRQL which assumes
Measurement and analysis of health related quality of life and environmental data
β Scribed by Mounir Mesbah
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 176 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1180-4009
- DOI
- 10.1002/env.680
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The definition (or construction) of variables and indicators, and the analysis of the evolution of their joint distribution between various populations, times and areas are generally two different, well separated steps of the work for a statistician in the field of environment and/or health related quality of life.
The first step generally deals with calibration and metrology of variables. Key words are measurement or scoring, depending on the area of application. Most of the time, the statistical methods used are exploratory. The kinds of models specified are generally structural: classical factorial analysis models or modern item response theory models. The second step is certainly more known by most inferential statisticians. Linear, generalized linear, time series and survival models are very useful models in this step, where the variables constructed in the first step are incorporated and their joint distribution with the other analysis variables (treatment group, time, duration of life, etc.) is investigated.
In this article, the simple strategy of separating the two steps is compared with the global strategy of defining and analysing a global model, including both the measurement and the analysis step. Copyright Β© 2004 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
458 insomniac patients participated in a multinational, randomised, double blind, parallel groups study of zopiclone 7.5 mg versus placebo. Patients received the drug or placebo nightly for 14 days and for a further six weeks on demand. Sleep characteristics and Quality of Life measures were assesse
## Abstract The objective of this study was to develop a new patientβreported outcome measure for patients with multiple system atrophy (MSA) and to test its psychometric properties. There were three stages. First, a pool of potential scale items was generated from inβdepth patient interviews. Seco